# FID-007 in Treating Participants With Advanced Solid Tumors

> **NCT03537690** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Southern California** · enrollment: 50 (actual)

## Conditions studied

- Advanced Malignant Solid Neoplasm
- Refractory Malignant Solid Neoplasm

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** PEOX-based Polymer Encapsulated Paclitaxel FID-007
- **OTHER:** Pharmacokinetic Study

## Key facts

- **NCT ID:** NCT03537690
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-05-25
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-05-25
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-04-29

## Collaborators

- National Cancer Institute (NCI)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03537690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03537690, "FID-007 in Treating Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03537690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*